Because of impaired signaling secondary to the binding of insulin to its receptor in T2DM, the activation of insulin-independent signaling proteins is attenuated in many tissues, including the liver, skeletal muscle, kidney, and bone [1–4], which leads to several serious consequences, particularly, osteoporosis [5–7]. This evidence concerns the gene INS and osteoporosis.